- Xenon Pharmaceuticals (NASDAQ:XENE) on Friday said the company has been added to the broad-market Russell 3000 and small-cap Russell 2000 Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025.
- Source: Press Release